.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Atenolol - Generic Drug Details

« Back to Dashboard
Atenolol is the generic ingredient in five branded drugs marketed by Zydus Pharms Usa, Pliva, Alvogen Malta, Able, Sun Pharm Inds Inc, Aurobindo Pharma, Teva, Apothecon, Teva Pharms, Sandoz, Mylan, Nostrum Labs, Dava Pharms Inc, Unique Pharm Labs, Watson Labs, Northstar Hlthcare, Astrazeneca, Sun Pharm Inds, SCS, Ipca Labs Ltd, and Mutual Pharm, and is included in forty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-three drug master file entries for atenolol. Fifty-eight suppliers are listed for this compound.

Summary for Generic Name: atenolol

Tradenames:5
Patents:0
Applicants:21
NDAs:44
Drug Master File Entries: see list33
Suppliers / Packaging: see list58
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: atenolol

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma
ATENOLOL
atenolol
TABLET;ORAL078512-001Oct 31, 2007RXNo► subscribe► subscribe
Sandoz
ATENOLOL
atenolol
TABLET;ORAL074265-001Feb 28, 1994DISCNNo► subscribe► subscribe
Apothecon
ATENOLOL
atenolol
TABLET;ORAL073318-001Mar 20, 1992DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: atenolol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-004Apr 9, 19903,836,671► subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-001Approved Prior to Jan 1, 19823,934,032► subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-002Approved Prior to Jan 1, 19823,836,671► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc